[Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].

@article{Medinger2004AdjuvantAP,
  title={[Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].},
  author={Michael Medinger and Simone Steinbild and Klaus G. Mross},
  journal={Praxis},
  year={2004},
  volume={93 40},
  pages={
          1633-44
        }
}
This article reviews the available data regarding the acticity of postoperative adjuvant systemic therapy for colorectal cancer as first and second-line treatment in metastatic disease. The efficacy of adjuvant treatment of patients with stage III colorectal cancer is well established. 5-fluorouracil (5-FU) and folic acid over 6 months (still) represent todays standard and should serve as comparison in randomized studies. The risk of relapse is low in stage II colon carcinoma and consequently… CONTINUE READING